Weight-Loss Drug May Slow Alzheimer's Decline
August 01, 2024
August 01, 2024
LONDON, England, Aug. 1 (TNSres) -- Imperial College-London issued the following news:
By Samantha Rey
A drug prescribed for diabetes and weight loss has been shown to reduce brain shrinkage in Alzheimer's patients by almost 50%.
The drug, called liraglutide, is one of the glucagon-like peptide receptor (GLP-1) agonists which also includes semaglutide - known as Wegovy or Ozempic - which are licensed for managing overweight and obesity and for type 2 diabet . . .
By Samantha Rey
A drug prescribed for diabetes and weight loss has been shown to reduce brain shrinkage in Alzheimer's patients by almost 50%.
The drug, called liraglutide, is one of the glucagon-like peptide receptor (GLP-1) agonists which also includes semaglutide - known as Wegovy or Ozempic - which are licensed for managing overweight and obesity and for type 2 diabet . . .